Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single-Center, Observational Study.

Xudong XieSiyuan ChenYawei CuiZhenzhen ZhouJianhua LuZhi DuJie DingKaidi XingYuesheng ZhangYijiang ZhouJun LiXiao-Gang Guo

Published in: Journal of the American Heart Association (2024)

PIMSRA allows for the reduction in the left ventricular outflow tract gradient and enhances symptomatic improvement, with a limited incidence of adverse events and complications among patients with hypertrophic obstructive cardiomyopathy.

Keyphrases

hypertrophic cardiomyopathy
radiofrequency ablation
left ventricular
risk factors
heart failure
cardiac resynchronization therapy
acute myocardial infarction
mitral valve
aortic stenosis
left atrial
type diabetes
coronary artery disease
metabolic syndrome
aortic valve
ultrasound guided